List of Excipients in API hydrocortisone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydrocortisone acetate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | CETYL ALCOHOL | |
Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | ETHYLENE DISTEARAMIDE | |
Meda Pharmaceuticals Inc | CORTIFOAM | hydrocortisone acetate | 0037-6830 | ISOBUTANE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydrocortisone acetate
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 | BENZYL CHLORIDE |
Crown Laboratories | hydrocortisone acetate | 0316-0140 | ISOPROPYL ALCOHOL |
Crown Laboratories | hydrocortisone acetate | 0316-0140 | PROPYLENE GLYCOL |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydrocortisone acetate
Excipient focus: BENZYL CHLORIDE
hydrocortisone acetate drug variants containing BENZYL CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing BENZYL CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
hydrocortisone acetate drug variants containing CARBOMER HOMOPOLYMER TYPE C
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
hydrocortisone acetate drug variants containing CETYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing CETYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
>Company | >Ingredient | >NDC |
Excipient focus: DIISOPROPYL ADIPATE
hydrocortisone acetate drug variants containing DIISOPROPYL ADIPATE
hydrocortisone acetate drug variants not containing DIISOPROPYL ADIPATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
hydrocortisone acetate drug variants containing DIMETHICONE
hydrocortisone acetate drug variants not containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
hydrocortisone acetate drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLENE DISTEARAMIDE
hydrocortisone acetate drug variants containing ETHYLENE DISTEARAMIDE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing ETHYLENE DISTEARAMIDE
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
hydrocortisone acetate drug variants containing GLYCERIN
hydrocortisone acetate drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED COCONUT OIL
hydrocortisone acetate drug variants containing HYDROGENATED COCONUT OIL
hydrocortisone acetate drug variants not containing HYDROGENATED COCONUT OIL
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOBUTANE
hydrocortisone acetate drug variants containing ISOBUTANE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing ISOBUTANE
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Sebela Pharmaceuticals Inc | hydrocortisone acetate and pramoxine hydrochloride | 54766-716 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
hydrocortisone acetate drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL MYRISTATE
hydrocortisone acetate drug variants containing ISOPROPYL MYRISTATE
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing ISOPROPYL MYRISTATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL PALMITATE
hydrocortisone acetate drug variants containing ISOPROPYL PALMITATE
hydrocortisone acetate drug variants not containing ISOPROPYL PALMITATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: LANOLIN
hydrocortisone acetate drug variants containing LANOLIN
hydrocortisone acetate drug variants not containing LANOLIN
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
hydrocortisone acetate drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Sebela Pharmaceuticals Inc | hydrocortisone acetate and pramoxine hydrochloride | 54766-716 |
>Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
hydrocortisone acetate drug variants containing PETROLATUM
hydrocortisone acetate drug variants not containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE
hydrocortisone acetate drug variants containing POLYOXYL 40 STEARATE
hydrocortisone acetate drug variants not containing POLYOXYL 40 STEARATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
hydrocortisone acetate drug variants containing POTASSIUM SORBATE
hydrocortisone acetate drug variants not containing POTASSIUM SORBATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
hydrocortisone acetate drug variants containing POVIDONE
hydrocortisone acetate drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPANE
hydrocortisone acetate drug variants containing PROPANE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing PROPANE
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Sebela Pharmaceuticals Inc | hydrocortisone acetate and pramoxine hydrochloride | 54766-716 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydrocortisone acetate drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
hydrocortisone acetate drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Sebela Pharmaceuticals Inc | hydrocortisone acetate and pramoxine hydrochloride | 54766-716 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
hydrocortisone acetate drug variants containing SODIUM METABISULFITE
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing SODIUM METABISULFITE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBIC ACID
hydrocortisone acetate drug variants containing SORBIC ACID
hydrocortisone acetate drug variants not containing SORBIC ACID
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOLAURATE
hydrocortisone acetate drug variants containing SORBITAN MONOLAURATE
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing SORBITAN MONOLAURATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN SESQUIOLEATE
hydrocortisone acetate drug variants containing SORBITAN SESQUIOLEATE
hydrocortisone acetate drug variants not containing SORBITAN SESQUIOLEATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARETH-10
hydrocortisone acetate drug variants containing STEARETH-10
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing STEARETH-10
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
hydrocortisone acetate drug variants containing STEARIC ACID
hydrocortisone acetate drug variants not containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
hydrocortisone acetate drug variants containing STEARYL ALCOHOL
hydrocortisone acetate drug variants not containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHANOLAMINE LAURYL SULFATE
hydrocortisone acetate drug variants containing TRIETHANOLAMINE LAURYL SULFATE
hydrocortisone acetate drug variants not containing TRIETHANOLAMINE LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
Excipient focus: TROLAMINE
hydrocortisone acetate drug variants containing TROLAMINE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing TROLAMINE
Company | Ingredient | NDC |
---|---|---|
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Sebela Pharmaceuticals Inc | hydrocortisone acetate and pramoxine hydrochloride | 54766-716 |
Sebela Pharmaceuticals Inc | hydrocortisone acetate and pramoxine hydrochloride | 54766-778 |
>Company | >Ingredient | >NDC |
Excipient focus: UREA
hydrocortisone acetate drug variants containing UREA
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing UREA
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
hydrocortisone acetate drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
hydrocortisone acetate drug variants containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | hydrocortisone acetate | 51672-3009 |
>Company | >Ingredient | >NDC |
hydrocortisone acetate drug variants not containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | hydrocortisone acetate | 0037-6830 |
Crown Laboratories | hydrocortisone acetate | 0316-0140 |
Rebel Distributors Corp | hydrocortisone acetate and pramoxine hydrochloride | 21695-982 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.